Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.

Lodygin D, Hermann M, Schweingruber N, Flügel-Koch C, Watanabe T, Schlosser C, Merlini A, Körner H, Chang HF, Fischer HJ, Reichardt HM, Zagrebelsky M, Mollenhauer B, Kügler S, Fitzner D, Frahm J, Stadelmann C, Haberl M, Odoardi F, Flügel A.

Nature. 2019 Mar;567(7749):E15. doi: 10.1038/s41586-019-1047-0.

PMID:
30867589
2.

β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.

Lodygin D, Hermann M, Schweingruber N, Flügel-Koch C, Watanabe T, Schlosser C, Merlini A, Körner H, Chang HF, Fischer HJ, Reichardt HM, Zagrebelsky M, Mollenhauer B, Kügler S, Fitzner D, Frahm J, Stadelmann C, Haberl M, Odoardi F, Flügel A.

Nature. 2019 Feb;566(7745):503-508. doi: 10.1038/s41586-019-0964-2. Epub 2019 Feb 20. Erratum in: Nature. 2019 Mar;567(7749):E15.

PMID:
30787438
3.

ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation.

Diercks BP, Werner R, Weidemüller P, Czarniak F, Hernandez L, Lehmann C, Rosche A, Krüger A, Kaufmann U, Vaeth M, Failla AV, Zobiak B, Kandil FI, Schetelig D, Ruthenbeck A, Meier C, Lodygin D, Flügel A, Ren D, Wolf IMA, Feske S, Guse AH.

Sci Signal. 2018 Dec 18;11(561). pii: eaat0358. doi: 10.1126/scisignal.aat0358.

PMID:
30563862
4.

Laquinimod enhances central nervous system barrier functions.

Lühder F, Kebir H, Odoardi F, Litke T, Sonneck M, Alvarez JI, Winchenbach J, Eckert N, Hayardeny L, Sorani E, Lodygin D, Flügel A, Prat A.

Neurobiol Dis. 2017 Jun;102:60-69. doi: 10.1016/j.nbd.2017.02.002. Epub 2017 Feb 22.

PMID:
28235673
5.

Intravital real-time analysis of T-cell activation in health and disease.

Lodygin D, Flügel A.

Cell Calcium. 2017 Jun;64:118-129. doi: 10.1016/j.ceca.2016.12.007. Epub 2016 Dec 28. Review.

PMID:
28126314
6.

Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.

Winter M, Lodygin D, Verdoodt B, Hermeking H.

Oncotarget. 2016 Jul 26;7(30):46862-46870. doi: 10.18632/oncotarget.10478.

7.

Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid.

Schläger C, Körner H, Krueger M, Vidoli S, Haberl M, Mielke D, Brylla E, Issekutz T, Cabañas C, Nelson PJ, Ziemssen T, Rohde V, Bechmann I, Lodygin D, Odoardi F, Flügel A.

Nature. 2016 Feb 18;530(7590):349-53. doi: 10.1038/nature16939. Epub 2016 Feb 10.

PMID:
26863192
8.

Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.

Wolf IM, Diercks BP, Gattkowski E, Czarniak F, Kempski J, Werner R, Schetelig D, Mittrücker HW, Schumacher V, von Osten M, Lodygin D, Flügel A, Fliegert R, Guse AH.

Sci Signal. 2015 Oct 13;8(398):ra102. doi: 10.1126/scisignal.aab0863.

PMID:
26462735
9.

Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR, Hermeking H.

J Clin Invest. 2015 Mar 2;125(3):1362. doi: 10.1172/JCI81340. Epub 2015 Mar 2. No abstract available.

10.

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR, Hermeking H.

J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18. Erratum in: J Clin Invest. 2015 Mar 2;125(3):1362.

11.

A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity.

Lodygin D, Odoardi F, Schläger C, Körner H, Kitz A, Nosov M, van den Brandt J, Reichardt HM, Haberl M, Flügel A.

Nat Med. 2013 Jun;19(6):784-90. doi: 10.1038/nm.3182. Epub 2013 Apr 28.

PMID:
23624600
12.

T cells become licensed in the lung to enter the central nervous system.

Odoardi F, Sie C, Streyl K, Ulaganathan VK, Schläger C, Lodygin D, Heckelsmiller K, Nietfeld W, Ellwart J, Klinkert WE, Lottaz C, Nosov M, Brinkmann V, Spang R, Lehrach H, Vingron M, Wekerle H, Flügel-Koch C, Flügel A.

Nature. 2012 Aug 30;488(7413):675-9. doi: 10.1038/nature11337.

PMID:
22914092
13.

Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system.

Cordiglieri C, Odoardi F, Zhang B, Nebel M, Kawakami N, Klinkert WE, Lodygin D, Lühder F, Breunig E, Schild D, Ulaganathan VK, Dornmair K, Dammermann W, Potter BV, Guse AH, Flügel A.

Brain. 2010 Jul;133(Pt 7):1930-43. doi: 10.1093/brain/awq135. Epub 2010 Jun 2.

14.

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.

Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J, Hermeking H.

Cell Cycle. 2008 Aug 15;7(16):2591-600. Epub 2008 Aug 1.

PMID:
18719384
15.

DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.

Zhang W, Bauer M, Croner RS, Pelz JO, Lodygin D, Hermeking H, Stürzl M, Hohenberger W, Matzel KE.

Dis Colon Rectum. 2007 Oct;50(10):1618-26; discussion 1626-7.

PMID:
17762966
16.

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H.

Cell Cycle. 2007 Jul 1;6(13):1586-93. Epub 2007 May 11.

PMID:
17554199
17.

c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability.

Menssen A, Epanchintsev A, Lodygin D, Rezaei N, Jung P, Verdoodt B, Diebold J, Hermeking H.

Cell Cycle. 2007 Feb 1;6(3):339-52. Epub 2007 Feb 3.

PMID:
17297307
18.

Epigenetic silencing of 14-3-3sigma in cancer.

Lodygin D, Hermeking H.

Semin Cancer Biol. 2006 Jun;16(3):214-24. Epub 2006 Apr 1. Review.

PMID:
16698281
19.

Functional epigenomics identifies genes frequently silenced in prostate cancer.

Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H.

Cancer Res. 2005 May 15;65(10):4218-27.

20.

The role of epigenetic inactivation of 14-3-3sigma in human cancer.

Lodygin D, Hermeking H.

Cell Res. 2005 Apr;15(4):237-46. Review.

21.

Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.

Lodygin D, Diebold J, Hermeking H.

Oncogene. 2004 Dec 2;23(56):9034-41.

PMID:
15489902
22.

Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.

Mhawech P, Benz A, Cerato C, Greloz V, Assaly M, Desmond JC, Koeffler HP, Lodygin D, Hermeking H, Herrmann F, Schwaller J.

Mod Pathol. 2005 Mar;18(3):340-8.

23.
24.
25.

Mutant loxP vectors for selectable marker recycle and conditional knock-outs.

Arakawa H, Lodygin D, Buerstedde JM.

BMC Biotechnol. 2001;1:7. Epub 2001 Sep 26.

26.

A large database of chicken bursal ESTs as a resource for the analysis of vertebrate gene function.

Abdrakhmanov I, Lodygin D, Geroth P, Arakawa H, Law A, Plachy J, Korn B, Buerstedde JM.

Genome Res. 2000 Dec;10(12):2062-9.

27.

[Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].

Kuz'min AI, Lodygin DN, Kalenikova EI, Bychkova EIu, Khokhlova ON, Murashev AN, Medvedev OS.

Eksp Klin Farmakol. 2000 Jul-Aug;63(4):24-8. Russian.

PMID:
11022301

Supplemental Content

Loading ...
Support Center